| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/04/2000 | US6084060 Amino acid sequence of protein that inhibits differentiation of progenitor cells; for expanding progenitor cell populations ex vivo to increase chances of engraftation and gene therapy |
| 07/04/2000 | US6083954 Method of treating cystic fibrosis |
| 07/04/2000 | US6083930 Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers |
| 07/04/2000 | US6083926 Water soluble vitamin B12 receptor modulating agents and methods related thereto |
| 07/04/2000 | US6083924 DnaB of staphylococcus aureus |
| 07/04/2000 | US6083923 Liposomal oligonucleotide compositions for modulating RAS gene expression |
| 07/04/2000 | US6083919 Administering synergistically effective amount of interleukin-10 and transforming growth factor-beta |
| 07/04/2000 | US6083918 Use of collagen for the treatment of degenerative articular processes |
| 07/04/2000 | US6083917 Farnesyltransferase inhibitor peptide having specified tetrapeptide sequence |
| 07/04/2000 | US6083916 Pharmaceutical product for application to uterus mucosa |
| 07/04/2000 | US6083915 Method for treating liver cancer |
| 07/04/2000 | US6083914 Antithrombotic peptides |
| 07/04/2000 | US6083913 Peptides and compounds that bind to a thrombopoietin receptor |
| 07/04/2000 | US6083912 Method for soft tissue augmentation |
| 07/04/2000 | US6083911 Arenavirus receptor and methods of use |
| 07/04/2000 | US6083910 Therapeutic uses of resolved intact or clipped native-sequence PDGF-BB dimers |
| 07/04/2000 | US6083909 Haemoglobin-hydroxyethyl starch conjugates as oxygen carriers |
| 07/04/2000 | US6083907 Treatment of peptic ulcers using midkine (MK) proteins |
| 07/04/2000 | US6083906 Method of regulating nitric oxide production or arthritis with soluble IL-17 receptor |
| 07/04/2000 | US6083905 Method and means for detecting and treating disorders in the blood coagulation cascade |
| 07/04/2000 | US6083904 Therapeutic and diagnostic methods and compositions based on notch proteins and nucleic acids |
| 07/04/2000 | US6083903 Boronic ester and acid compounds, synthesis and uses |
| 07/04/2000 | US6083902 Recombinant fibrin chains, fibrin and fibrin-homologs |
| 07/04/2000 | US6083751 Chimeric receptors for the generation of selectively-activatable TH-independent cytotoxic T cells |
| 07/04/2000 | US6083749 DNA encoding a human serotonin receptor (5-HT4B) and uses thereof |
| 07/04/2000 | US6083746 Genes and genetic elements associated with control of neoplastic transformation in mammalian cells |
| 07/04/2000 | US6083745 Genes and genetic elements associated with control of neoplastic transformation in mammalian cells |
| 07/04/2000 | US6083744 DNA-armed ribozymes and minizymes |
| 07/04/2000 | US6083735 Programmed cell death genes and proteins |
| 07/04/2000 | US6083725 Nucleotide sequences coding a mammalian enzymatic polypeptide; for gene therapy of lysosomal storage defect |
| 07/04/2000 | US6083724 Recombinant avian interferon-gamma (IFN-γ) |
| 07/04/2000 | US6083723 Vector comprising regulatory nucleotide sequences and nucleic acids that code for a exogenous polypeptide |
| 07/04/2000 | US6083721 Isolated nucleic acid molecules encoding PARG, a GTPase activating protein which interacts with PTPL1 |
| 07/04/2000 | US6083719 Cytidine deaminase cDNA as a positive selectable marker for gene transfer, gene therapy and protein synthesis |
| 07/04/2000 | US6083716 Chimpanzee adenovirus vectors |
| 07/04/2000 | US6083713 Nucleotide sequences coding binding polypeptide for the terminal domain of the amyloid precursor protein; for the diagnosis and design of drugs for treatment of alzheimer's disease |
| 07/04/2000 | US6083711 Proteases compositions capable of binding to said site, and methods of use thereof |
| 07/04/2000 | US6083705 Screening for chemical compound which preferentially binds to binding protein; incubation of compound with cells expressing binding protein, detecting preferential binding of compound to surface of cell not normally expressing binding protein |
| 07/04/2000 | US6083704 Human cytochrome b5 |
| 07/04/2000 | US6083703 Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes |
| 07/04/2000 | US6083702 Methods and compositions for use in spliceosome mediated RNA trans-splicing |
| 07/04/2000 | US6083691 Nucleotide sequences which code for a gene which expresses a protein which plays a role in the regulation of glycoprotein coating on the surface of bacterial cells; diagnosing and treating humans with bacterial infection |
| 07/04/2000 | US6083688 Expression vectors which codes for a human polypeptide marker of megakaryocytic cells |
| 07/04/2000 | US6083684 Viral products |
| 07/04/2000 | US6083534 Pharmaceutical compositions for controlled release of soluble receptors |
| 07/04/2000 | US6083523 Implantable biocompatable immunoisolatory vehicle for delivery of selected therapeutic products |
| 07/04/2000 | US6083521 Drugs and polyethylene carbonates |
| 07/04/2000 | US6083515 Treating inflammation, pain, gastrointestinal lesions or fever in an animal in need thereof with reduction of the gastrointestinal toxicity or renal toxicity of the nonsteroidal antiinflammatory drug |
| 07/04/2000 | US6083504 Human monoclonal antibodies directed against the transmembrane glycoprotein (GP41) of human immunodeficiency virus-1 (HIV-1) |
| 07/04/2000 | US6083503 Administering an antigen specifically recognized by t cells to cause the t cells that specifically recognize the antigen to express interleukin-2 or il-2 receptors, such that the t cell immune response to the antigen is inhibited |
| 07/04/2000 | US6083501 Drug for prevention and therapy of diseases caused by fibrinoid formation or thrombus formation in the lung and model animals of the diseases |
| 07/04/2000 | US6083480 Calcitonin receptor binding reagents |
| 07/04/2000 | US6083478 Consists of a cytotoxic radionuclide and a homodimer comprising two heavy chains encoded by the expression vector designated cd4-igg2-pcdna1 (atcc no. 40952) |
| 07/04/2000 | US6083477 Useful therapeutic reagents for treating leukemias and lymphomas;conjugate of a non-immunogenic rnase or a therapeutic radionuclide that is an alpha-emitter or a beta-emitter and a cell-specific cytokine |
| 07/04/2000 | US6082364 Pluripotential bone marrow cell line and methods of using the same |
| 07/04/2000 | CA2124792C Methods for the treatment of osteoporosis using bisphosphonates and parathyroid hormone |
| 07/04/2000 | CA2103021C Recombinant dna coding for signal peptide, selective interacting polypeptide and membrane anchoring sequence |
| 06/30/2000 | CA2256123A1 A novel hypertension related calcium regulated gene (hcarg) |
| 06/29/2000 | WO2000037685A2 Method of identifying a psychotropic agent using differential gene expression |
| 06/29/2000 | WO2000037679A2 Method for determining the susceptibility to developing sepsis and therapeutics for the treatment of sepsis |
| 06/29/2000 | WO2000037664A1 Method for preparing suspension of stable posiplexes |
| 06/29/2000 | WO2000037659A1 Non-viral transfection vector |
| 06/29/2000 | WO2000037648A1 Protective antigen of group a streptococci (spa) |
| 06/29/2000 | WO2000037643A2 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use |
| 06/29/2000 | WO2000037642A1 Method of enhancing the biological activity of ligands |
| 06/29/2000 | WO2000037641A2 Vascular endothelial growth factor-x |
| 06/29/2000 | WO2000037640A2 Compositions and methods for the treatment of tumor |
| 06/29/2000 | WO2000037639A2 Lymphocytic membrane proteins |
| 06/29/2000 | WO2000037638A2 Methods and compositions for inhibiting neoplastic cell growth |
| 06/29/2000 | WO2000037637A1 Novel protein and dna thereof |
| 06/29/2000 | WO2000037636A1 Socs-box containing peptides |
| 06/29/2000 | WO2000037635A2 Genetic suppressor elements against human immunodeficiency virus |
| 06/29/2000 | WO2000037634A2 Novel polypeptides and nucleic acids encoding same |
| 06/29/2000 | WO2000037630A1 Secreted proteins |
| 06/29/2000 | WO2000037613A2 Human akt-3 |
| 06/29/2000 | WO2000037612A1 SOMATIC CELLS WITH ABLATED Prp GENE AND METHODS OF USE |
| 06/29/2000 | WO2000037609A2 Orally immunogenic bacterial enterotoxins expressed in transgenic plants |
| 06/29/2000 | WO2000037608A2 Micromonospora echinospora genes encoding for biosynthesis of calicheamicin and self-resistance thereto |
| 06/29/2000 | WO2000037502A2 Vascular endothelial cell growth factor antagonists and uses thereof |
| 06/29/2000 | WO2000037500A1 Three dimensional structure of a sterile alpha motif domain |
| 06/29/2000 | WO2000037499A1 Topoisomerase ii inhibitor |
| 06/29/2000 | WO2000037498A1 THE POLYPEPTIDE DREAM, USED AS Ca2+IONS-DEPENDENT TRANSCRIPTIONAL REGULATOR AND ITS GENE CODING THEREFOR |
| 06/29/2000 | WO2000037495A1 EF-Tu |
| 06/29/2000 | WO2000037494A2 Chlamydia trachomatis antigens |
| 06/29/2000 | WO2000037491A2 Dnas encoding proteins with signal sequences |
| 06/29/2000 | WO2000037490A2 Outer surface proteins, their genes, and their use |
| 06/29/2000 | WO2000037487A1 αvβ6 INTEGRIN INHIBITORS |
| 06/29/2000 | WO2000037482A2 Peptides and peptide analogues designed from hfe protein and their uses in the treatment of iron overload diseases |
| 06/29/2000 | WO2000037455A1 Benzothiepin-anilide derivatives, their production and their use for antagonizing ccr-5 |
| 06/29/2000 | WO2000037444A1 Compounds useful in the treatment of inflammatory diseases |
| 06/29/2000 | WO2000037429A2 INHIBITORS OF α4β1 MEDIATED CELL ADHESION |
| 06/29/2000 | WO2000037124A1 Injectable hyaluronic acid derivative with pharmaceuticals/cells |
| 06/29/2000 | WO2000037110A2 Ribavirin-pegylated interferon alfa induction hcv combination therapy |
| 06/29/2000 | WO2000037107A2 Use of cyclooxygenase-2 inhibitor, a matrix metallaproteinase inhibitor, an antineoplastic agent and optionally radiation as a combination treatment of neoplasia |
| 06/29/2000 | WO2000037105A2 Streptococcus pneumoniae proteins and immunogenic fragments for vaccines |
| 06/29/2000 | WO2000037099A2 Method for accelerating the rate of mucociliary clearance by using a kunitz-type serine protease inhibitor |
| 06/29/2000 | WO2000037098A1 Shelf-stable formulation of glucagon-like peptide-1 |
| 06/29/2000 | WO2000037097A1 Ribavirin-interferon alfa induction hcv combination therapy |
| 06/29/2000 | WO2000037096A2 Treatment of hepatitis c virus infections with interleukin-10 |
| 06/29/2000 | WO2000037095A1 Cardiac muscle function and manipulation |